CHLORTHALIDONE
| Brand name | HEMICLOR |
|---|---|
| Active ingredient | CHLORTHALIDONE |
| Strength | 12.5MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2025 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12667554 | September 2045 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.